Skip to main content

Find Clinical Trials

Home
Conditions
Genomic Instability

Clinical trial condition

Genomic Instability

Explore clinical trials studying Genomic Instability. Study availability and eligibility vary by location and protocol.

33 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Genomic Instability trial results

Active, Not Recruiting

iRECIST Evaluation's Relevance for DCR in MMR/MSI Metastatic Colorectal Cancer Patients on Nivolumab and Ipilimumab

NCT03350126

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +13 more
Locations: Institut Sainte Catherine Avignon, France

CHRU Besançon Besançon, France

Henri Mondor Hospital Créteil, France

IHFB Levallois-Perret, France

View Trial Details

Active, Not Recruiting

Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma.

NCT04006262

Conditions: Genomic Instability, Localized Oesogastric Adenocarcimona, MSI and or dMMR, +3 more
Locations: CHRU Jean Minjoz Besançon, France

Hôpital Henri Mondor Créteil, France

Institut Hospitalier Franco-Britannique Levallois-Perret, France

CHRU Lille Lille, France

View all 15 locations

View Trial Details

Active, Not Recruiting

TremelImumab aNd Durvalumab For the Non-operatIve Management (NOM) of MSI-high Resectable GC/GEJC.

NCT04817826

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +10 more
Locations: Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Milan, Italy

View Trial Details